Susquehanna International Group, LLP Brooklyn Immuno Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $0.71 $1,745 - $5,388	-7,590 Reduced 18.15%	34,223 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.48 - $2.03 $14,507 - $61,352	30,223 Added 260.77%	41,813 $22,000
Q3 2021 Nov 15, 2021	SELL	$8.86 - $17.05 $738,764 - $1.42 Million	-83,382 Reduced 87.8%	11,590 $108,000
Q2 2021 Aug 11, 2021	BUY	$3.75 - $78.5 $356,145 - $7.46 Million	94,972 New	94,972 $1.71 Million

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.